Innoviva Inc (INVA)
19.06
-0.09
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
+0.02
(+0.08%)
After-Hours: 20:00
Innoviva Enterprise Value: 1.380B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.380B |
| November 20, 2024 | 1.386B |
| November 19, 2024 | 1.382B |
| November 18, 2024 | 1.373B |
| November 15, 2024 | 1.370B |
| November 14, 2024 | 1.392B |
| November 13, 2024 | 1.445B |
| November 12, 2024 | 1.459B |
| November 11, 2024 | 1.447B |
| November 08, 2024 | 1.450B |
| November 07, 2024 | 1.439B |
| November 06, 2024 | 1.434B |
| November 05, 2024 | 1.404B |
| November 04, 2024 | 1.399B |
| November 01, 2024 | 1.393B |
| October 31, 2024 | 1.412B |
| October 30, 2024 | 1.421B |
| October 29, 2024 | 1.432B |
| October 28, 2024 | 1.435B |
| October 25, 2024 | 1.425B |
| October 24, 2024 | 1.427B |
| October 23, 2024 | 1.428B |
| October 22, 2024 | 1.437B |
| October 21, 2024 | 1.430B |
| October 18, 2024 | 1.441B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.450B |
| October 16, 2024 | 1.452B |
| October 15, 2024 | 1.432B |
| October 14, 2024 | 1.432B |
| October 11, 2024 | 1.427B |
| October 10, 2024 | 1.407B |
| October 09, 2024 | 1.417B |
| October 08, 2024 | 1.429B |
| October 07, 2024 | 1.423B |
| October 04, 2024 | 1.419B |
| October 03, 2024 | 1.408B |
| October 02, 2024 | 1.412B |
| October 01, 2024 | 1.408B |
| September 30, 2024 | 1.396B |
| September 27, 2024 | 1.439B |
| September 26, 2024 | 1.415B |
| September 25, 2024 | 1.410B |
| September 24, 2024 | 1.413B |
| September 23, 2024 | 1.413B |
| September 20, 2024 | 1.441B |
| September 19, 2024 | 1.461B |
| September 18, 2024 | 1.453B |
| September 17, 2024 | 1.463B |
| September 16, 2024 | 1.484B |
| September 13, 2024 | 1.470B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
876.81M
Minimum
Mar 18 2020
1.871B
Maximum
Apr 08 2022
1.316B
Average
1.339B
Median
Jul 23 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.273M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.213M |
| Revenue (Quarterly) | 89.51M |
| Total Expenses (Quarterly) | 46.27M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 88.84% |
| Profit Margin (Quarterly) | 1.36% |
| Earnings Yield | 3.62% |
| Operating Earnings Yield | 11.47% |
| Normalized Earnings Yield | 6.889 |